Abstract
This Practice Point commentary discusses a recent study by Forman et al. that examined the association between baseline urinary albumin:creatinine ratio and the risk of developing hypertension among 2,179 women in the first and second Nurses' Health Studies who did not have hypertension or diabetes at baseline and had normoalbuminuria by conventional definitions. The study showed that quartiles of albuminuria beyond the lowest quartile were increasingly predictive of subsequent hypertensive disease, even at levels well below what is conventionally considered to be the normal range. This commentary highlights the importance of evaluating albuminuria as an indicator of target organ damage and a risk factor for cardiovascular disease. Patients without hypertension, diabetes or other cardiovascular diseases who have albuminuria should be considered at risk of cardiovascular disease and should undergo intensive follow-up. In addition, although previous studies have indicated that cardiovascular risk increases exponentially with increasing levels of albuminuria, the definition of the threshold for albuminuria should be dependent on concomitant cardiovascular disease (i.e. lower levels of albuminuria should be considered pathologic if concomitant cardiovascular disease is not present).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mancia G et al. (2007) 2007 guidelines for the management of arterial hypertension. J Hypertens 25: 1105–1187
Forman JP et al. (2008) Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol [10.1681/ASN.2008010038]
Wang TJ et al. (2005) Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 111: 1370–1376
Gerstein HC et al. (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421–426
Wachtell K et al. (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139: 901–906
Olsen MH et al. (2008) Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens 26: 26–34
Ibsen H et al. (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 45: 198–202
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Wachtell, K., Olsen, M. Is it time to change the definition of normal urinary albumin excretion?. Nat Rev Nephrol 4, 650–651 (2008). https://doi.org/10.1038/ncpneph0971
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0971